Jump to content

LCIS

From Surgopaedia

A non-invasive lesion that arises from the lobules and terminal ducts of the breast.

Pathophysiology

[edit | edit source]
  • Recognised by its conformity to the outline of the normal lobule, with expanded and filled acini
  • Variant - pleomorphic LCIS - a distinct, more aggressive subtype
    • Shows nuclear pleomorphism compared with classic LCIS
    • One or more lobules are distended by discohesive cells with irregularly-shaped, high-grade nuclei
    • May or may not be associated with comedonecrosis and calcifications
    • Controversial, but some suggest it should be excised and treated like DCIS
  • Florid LCIS is another more aggressive variant

Presentation

[edit | edit source]
  • Uncommon condition, predominantly seen in younger pre-menopausal women
  • Often found incidentally on biopsy
  • Does not manifest as palpable mass or microcalcifications on mammography

Treatment

[edit | edit source]
  • If found incidentally:
    • If core biopsy only shows classic LCIS, and radiology is concordant, observe with clinical and imaging follow-up. Very low upgrade rates (<3%).
    • Pleomorphic or florid LCIS should be excised to negative margins.
  • Treatment options
    • Close surveillance
      • Annual mammography and consider annual MRI (ideally, alternate these every 6 months)
    • Chemoprevention
      • Significant risk reduction with SERMs or Ais (reduces 5-year risk of invasive cancer by about 50%)
    • Bilateral mastectomy
      • 90-95% risk reduction
      • Consider for women with additional risk factors

Prognosis

[edit | edit source]
  • Typically thought of as a marker of increased risk of developing breast cancer in the future, however this is controversial
  • Not currently considered to be a preinvasive breast cancer
  • Estimated lifetime risk of developing breast cancer is 30-40% (applies to both breasts, but higher risk in ipsilateral breast). Sabiston quotes actuarial risk of getting cancer within 35 years of 21.4%.
  • RR of 7 for breast cancer
  • 40% of cancers subsequently developing in patients with LCIS were in situ lesions. The invasive cancers that DID develop were predominantly ductal and not lobular, and 50% occurred in the contralateral breast.